Curative Biotechnology (Curative Biotechnology) EV-to-Revenue : (As of Jun. 09, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Curative Biotechnology EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Curative Biotechnology's enterprise value is $0.00 Mil. Curative Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00 Mil. Therefore, Curative Biotechnology's EV-to-Revenue for today is .

The historical rank and industry rank for Curative Biotechnology's EV-to-Revenue or its related term are showing as below:

CUBT's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.86
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-09), Curative Biotechnology's stock price is $0.01685. Curative Biotechnology's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00. Therefore, Curative Biotechnology's PS Ratio for today is .

Curative Biotechnology EV-to-Revenue Historical Data

The historical data trend for Curative Biotechnology's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biotechnology EV-to-Revenue Chart

Curative Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-Revenue

Get a 7-Day Free Trial

Curative Biotechnology Quarterly Data
	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Curative Biotechnology's EV-to-Revenue

For the Biotechnology subindustry, Curative Biotechnology's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curative Biotechnology's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curative Biotechnology's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Curative Biotechnology's EV-to-Revenue falls into.

Curative Biotechnology EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Curative Biotechnology's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	0.000	/	0
	=

Curative Biotechnology's current Enterprise Value is $0.00 Mil.
Curative Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Curative Biotechnology (OTCPK:CUBT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Curative Biotechnology's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.01685	/	0
	=

Curative Biotechnology's share price for today is $0.01685.
Curative Biotechnology's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

Curative Biotechnology EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Curative Biotechnology's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biotechnology (Curative Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curative Biotechnology Inc (OTCPK:CUBT) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1825 NW Corporate Boulevard, Suite 110, Boca Raton, FL, USA, 33431

Website

https://www.curativebiotech.com

Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The company currently has ongoing programs in three therapeutic areas: Infectious Disease, Neuro-Oncology, and Degenerative Eye Disease.